SHIELD will evaluate valacyclovir, celecoxib, and a 25-day course of nirmatrelvir/ritonavir against placebo in approximately 150 adults aged 18 to 65 with Long COVID. The primary endpoint is the EQ-5D ...
DURHAM, N.C., Dec. 8, 2020 /PRNewswire/ -- Neuropsychopharmacology recently published "Placebo Response Mitigation with a Participant-Focused Psychoeducational Procedure: A Randomized, Single-Blind, ...
The 58 participant, randomized, double-blind, placebo-controlled study was led by Edmarie Guzmán-Vélez, PhD, formerly an Assistant Professor in the Department of Psychiatry and the McCance Center for ...
Add Yahoo as a preferred source to see more of our stories on Google. In picking Robert F. Kennedy Jr. to lead the U.S. Department of Health and Human Services, President-elect Donald Trump is ...
In making similar claims about placebo-controlled studies, vaccine skeptics often take a narrow view of what a "placebo" is, arguing it can only be water or saltwater. In reality, there’s a larger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results